|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Technology and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Unrealized gain on equity investment | |||||
| Interest income | |||||
| Interest income | |||||
| Unrealized loss on equity investments | |||||
| Other income (expense), net | |||||
| Total other income, net | |||||
| Income before provision for (benefit from) income taxes | |||||
| Provision for (benefit from) income taxes | |||||
| Net income (loss) | |||||
| Net income (loss) per share attributable to common stockholders: | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Weighted-average shares used to compute net income (loss) per share attributable to common stockholders: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...